Correction: Correlation of Group C Meningococcal Conjugate Vaccine Response with B- and T-Lymphocyte Activity.

Correction: Correlation of Group C Meningococcal Conjugate Vaccine Response with B- and T-Lymphocyte Activity.

Detalles Bibliográficos
Main Authors:	James B. Wing, Lynne Smart, Ray Borrow, Jamie Findlow, Helen Findlow, Andrew Lees, Robert C. Read, Andrew W. Heath
Formato:	Artigo
Idioma:	English
Publicado:	Public Library of Science (PLoS) 2012-01-01
Series:	PLoS ONE
Acceso en liña:	http://europepmc.org/articles/PMC3553198

Títulos similares

Correlation of group C meningococcal conjugate vaccine response with B- and T-lymphocyte activity.
por: James B Wing, et al.
Publicado: (2012-01-01)

A review of complement sources used in serum bactericidal assays for evaluating immune responses to meningococcal ACWY conjugate vaccines
por: Jamie Findlow, et al.
Publicado: (2019-10-01)

The important lessons lurking in the history of meningococcal epidemiology
por: Ray Borrow, et al.
Publicado: (2024-12-01)

Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in healthy toddlers: a Phase II randomized study
por: Timo Vesikari, et al.
Publicado: (2020-06-01)

National and regional differences in meningococcal vaccine recommendations for individuals at an increased risk of meningococcal disease
por: Cynthia Burman, et al.
Publicado: (2023-12-01)

Correction: Correlation of Group C Meningococcal Conjugate Vaccine Response with B- and T-Lymphocyte Activity
Publicado: (2012-01-01)

Effectiveness of Meningococcal B Vaccine against Endemic Hypervirulent Neisseria meningitidis W Strain, England
por: Shamez Ladhani, et al.
Publicado: (2016-02-01)

Invasive Meningococcal Capsular Group Y Disease, England and Wales, 2007–2009
por: Shamez N. Ladhani, et al.
Publicado: (2012-01-01)

Systematic literature review of the impact and effectiveness of monovalent meningococcal C conjugated vaccines when used in routine immunization programs
por: Myint Tin Tin Htar, et al.
Publicado: (2020-12-01)

Epidemiologic Trends, Global Shifts in Meningococcal Vaccination Guidelines, and Data Supporting the Use of MenACWY-TT Vaccine: A Review
por: Jessica Presa, et al.
Publicado: (2019-07-01)

Maintenance of immune response throughout childhood following serogroup C meningococcal conjugate vaccination in early childhood.
por: Khatami, A, et al.
Publicado: (2011)

Global Epidemiology of Meningococcal Disease-Causing Serogroups Before and After the COVID-19 Pandemic: A Narrative Review
por: Steven Shen, et al.
Publicado: (2024-11-01)

Meningococcal serogroup A, C, W, and Y serum bactericidal antibody profiles in Hajj pilgrims
por: Ziad A. Memish, et al.
Publicado: (2014-11-01)

Invasive Meningococcal Disease in the Post-COVID World: Patterns of Disease Rebound
por: Jamie Findlow, et al.
Publicado: (2025-02-01)

Emergency Meningococcal ACWY Vaccination Program for Teenagers to Control Group W Meningococcal Disease, England, 2015–2016
por: Helen Campbell, et al.
Publicado: (2017-07-01)

Review of clinical studies comparing meningococcal serogroup C immune responses induced by MenACWY-TT and monovalent serogroup C vaccines
por: Lidia Serra, et al.
Publicado: (2021-07-01)

Commentary: Variant Signal Peptides of Vaccine Antigen, FHbp, Impair Processing Affecting Surface Localization and Antibody-Mediated Killing in Most Meningococcal Isolates
por: Paul Liberator, et al.
Publicado: (2020-11-01)

The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection
por: Ray Borrow, et al.
Publicado: (2017-04-01)

Meningococcal Group W Disease in Infants and Potential Prevention by Vaccination
por: Sydel R. Parikh, et al.
Publicado: (2016-08-01)

Immunogenicity of the UK group B meningococcal vaccine (4CMenB) schedule against groups B and C meningococcal strains (Sched3): outcomes of a multicentre, open-label, randomised controlled trial
por: Davis, K, et al.
Publicado: (2021)

Immunogenicity and immunologic memory of meningococcal C conjugate vaccine in premature infants.
por: Collins, C, et al.
Publicado: (2005)

Quadrivalent meningococcal conjugate vaccines
por: Pace, D, et al.
Publicado: (2009)

Quadrivalent meningococcal conjugate vaccines.
por: Pace, D, et al.
Publicado: (2009)

Immunogenicity of two investigational serogroup B meningococcal vaccines in the first year of life: a randomized comparative trial.
por: Snape, MD, et al.
Publicado: (2010)

Herd Protection against Meningococcal Disease through Vaccination
por: Stephen A. Clark, et al.
Publicado: (2020-10-01)

An overview of the meningococcal disease and impact of the quadrivalent meningococcal conjugate vaccine
por: Asmaa Alrobai, et al.
Publicado: (2021-12-01)

The distribution and 'in vivo' phase variation status of haemoglobin receptors in invasive meningococcal serogroup B disease: genotypic and phenotypic analysis.
por: Jay Lucidarme, et al.
Publicado: (2013-01-01)

Immunogenicity and reactogenicity of a reduced schedule of a 4-component capsular group B meningococcal vaccine: a randomized controlled trial in infants
por: Valente Pinto, M, et al.
Publicado: (2020)

Meningococcal polysaccharide-protein conjugate vaccines.
por: Snape, MD, et al.
Publicado: (2005)

Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian children
por: Samba O. Sow, et al.
Publicado: (2023-08-01)

Introduction of a second MenB vaccine into Europe – needs and opportunities for public health
por: Jamie Findlow, et al.
Publicado: (2019-03-01)

Meningococcal disease. Meningococcal conjugate polysaccharide vaccines and new generation vaccines. Report 3
por: M. V. Abramtseva, et al.
Publicado: (2018-02-01)

Progress in meningococcal conjugate vaccine development and use
Publicado: (2020-06-01)

Meningococcal conjugate vaccines: optimizing global impact
por: Terranella A, et al.
Publicado: (2011-09-01)

Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy.
por: Findlow, J, et al.
Publicado: (2010)

B cell responses to conjugate and polysaccharide meningococcal vaccines
por: Ramasamy, M
Publicado: (2012)

Impact of serogroup A meningococcal conjugate vaccine for Africa
por: James M. Stuart
Publicado: (2018-05-01)

Current safety issues with quadrivalent meningococcal conjugate vaccines
por: Tanya R. Myers, et al.
Publicado: (2018-05-01)

Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease
por: Hedari CP, et al.
Publicado: (2014-04-01)

Impact of meningococcal group B OMV vaccines, beyond their brief
por: Helen Petousis-Harris
Publicado: (2018-05-01)